testicular non-seminomatous germ cell cancer
Disease Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

ID DOID:5345
Name testicular non-seminomatous germ cell cancer
Definition A testicular malignant germ cell cancer that is characterized by the absence of a seminomatous component.
Source DiseaseOntology.org
Alt Ids DOID:4086
Xrefs
ICDO:9065/3
SNOMEDCT_US_2023_03_01:107691000119101
Path disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer male reproductive organ cancer testicular cancer testicular germ cell cancer testicular malignant germ cell cancer testicular non-seminomatous germ cell cancer

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT02834013 Phase II Ipilimumab + Nivolumab Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Active, not recruiting USA 1
NCT06937866 Phase Ib/II Etoposide + XL092 Maintenance Zanzalintinib With Etoposide After HDCT in GCT Recruiting USA 0